TOMI Environmental Solutions Receives Biocidal Product Approvals in Great Britain and Northern Ireland
MWN-AI** Summary
TOMI Environmental Solutions, Inc.® (NASDAQ: TOMZ) has announced a significant advancement in its operations with the receipt of biocidal product approvals for its Binary Ionization Technology (BIT) solution and SteraMist iHP disinfection equipment in Great Britain and Northern Ireland. The Health and Safety Executive (HSE), responsible for health and safety regulation in Great Britain, has officially authorized the BIT solution as a biocidal product in accordance with Regulation 528/2012. Northern Ireland has granted similar approval under the EU’s Biocidal Products Regulation.
This approval milestone will facilitate the expansion of TOMI's technological reach across various sectors, including healthcare, industrial, and hospitality, by allowing the BIT solution to be utilized for room fogging and handheld spray applications as a microbial disinfectant on various surfaces. TOMI's COO, Elissa J. Shane, expressed optimism about this achievement, highlighting its role in enhancing the company's market presence and commitment to rigorous compliance standards. Further approvals are sought under the EU Biocidal Products Regulation, potentially enabling TOMI to enter more European markets.
The BIT solution is specifically engineered for disinfecting dry, pre-cleaned hard surfaces in diverse environments such as pharmaceutical clean rooms, laboratories, and hotels, among others. Efficacy claims for the BIT solution include notable bactericidal, yeasticidal, and virucidal properties validated through various testing methodologies.
TOMI’s SteraMist disinfection products produce a fog of ionized Hydrogen Peroxide (iHP™), a non-caustic aerosol effective in numerous applications. The company, committed to innovative disinfection solutions, actively participates in organizations like the American Biological Safety Association and the Society for Healthcare Epidemiology of America, ensuring its products meet the highest safety standards.
MWN-AI** Analysis
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) has recently secured biocidal product approvals for its Binary Ionization Technology (BIT) and SteraMist iHP disinfection solutions in Great Britain and Northern Ireland. This milestone opens new avenues for TOMI, granting it the ability to expand its market presence across key segments such as healthcare, hospitality, and industrial applications.
From an investment perspective, TOMI's strategic regulatory approvals are likely to bolster its revenue growth, considering the increasing global emphasis on effective infection control amidst ongoing health concerns. The biocidal products' recognition under Regulation 528/2012 not only legitimizes the safety and efficacy of TOMI's offerings but also positions the company advantageously against competitors in the rapidly evolving disinfection market.
Investors should monitor TOMI’s ongoing efforts to gain EU-wide approval for its BIT solutions. Success in this endeavor would enhance TOMI’s market penetration across Europe, potentially becoming a cornerstone of its business strategy. The company's proactive expansion is commendable—particularly in a diverse set of sectors that require rigorous sanitation protocols.
Financially, TOMI's growth trajectory hinges on its ability to manage and capture new customer segments, as well as its reliance on a select few products for revenue generation. Given the nature of the pandemic-driven market, TOMI appears poised to leverage these approvals into increased sales, making them an attractive opportunity in the biotech and environmental solutions sectors.
While the company faces inherent risks—including regulatory dependencies and market competition—investors may find TOMI's focus on innovative solutions and compliance with strict health regulations a compelling proposition. As always, investors should consider their own risk tolerance and conduct thorough research prior to investment, especially in emerging sectors tied to public health and safety.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
FREDERICK, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced that Health and Safety Executive (HSE), Great Britian’s national regulator for health and safety, has granted official authorization for its Binary Ionization Technology (BIT) solution and the SteraMist iHP brand of disinfection equipment. The BIT Solution is now formally approved as a biocidal product for use in Great Britain, which includes England, Scotland, and Wales under Regulation 528/2012 GB. A separate approval was also received for Northern Ireland under Regulation (EU) No. 528/2012.
This milestone marks a significant achievement for TOMI, as it paves the way for expanding the availability of BIT and SteraMist products in both Great Britain and Northern Ireland. The BIT solution is approved under Regulation 528/2012 for room fogging and handheld direct spray applications. It is intended for use as a microbial disinfectant on surfaces, walls, floors, furniture, and rooms across various sectors, including healthcare, industrial, commercial, hospitality, and institutional settings.
Elissa J. Shane, COO of TOMI, stated, “This not only enhances our market footprint but also reinforces our commitment to providing innovative solutions that meet rigorous compliance, safety, and efficacy standards. We are optimistic that our separate application under the EU Biocidal Products Regulation (BPR) for the European Union will also be approved this year, opening doors in additional countries across Europe.”
The BIT solution is designed for disinfection of all dry, pre-cleaned, hard, non-porous, non-food contact surfaces in spaces such as pharmaceutical manufacturing clean rooms, tissue labs, laboratories, animal research facilities, hotel rooms, cruise ships, and recreational facilities.
The following efficacy claims have been established for TOMI's BIT solution in Great Britain:
| STANDARD | CONTACT TIME | STANDARD | CONTACT TIME | STANDARD | CONTACT TIME |
| Bactericidal | Yeasticidal | Virucidal | |||
| SURFACE APPLICATION | |||||
| EN 13727 | 5 min. | EN 13624 | 5 min. | EN 14476 | 5 min. |
| AOAC Germicidal Spray Method; NF-T 72-281; EN 13697 | 7 min. | NF T 72-281; EN 13697 | 7 min. | AOAC Germicidal Spray Method; NF T 72-281: | 7 min. |
| ROOM FOGGING | |||||
| EN 13727 | 5 min | EN 13624 | 5 min | EN 14476 | 5 min |
| NF T 72-281 EN 13697; AOAC Germicidal Fog Method | 15 min. | NF T 72-281; EN 13697 | 15 min. | NF T 72-28; AOAC Germicidal Spray Method | 15 min. |
TOMI’s SteraMist products utilize a low percentage of Hydrogen Peroxide as the only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™), which creates a germ-killing aerosol that functions like a non-caustic gas. These products are designed for a wide range of applications, including hospitals, medical facilities, schools, restaurants, military barracks, and more.
About TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (NASDAQ: TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.
TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.
TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.
For additional information, please visit https://www.steramist.com or contact us at info@tomimist.com.
Forward-Looking Statements
This press release contains forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to TOMI’s products and services serving the food safety sector. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, our ability to acquire new customers and expands sales; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.
INVESTOR RELATIONS CONTACT:
John Nesbett/Rosalyn Christian
IMS Investor Relations
FAQ**
How will the approval of TOMI Environmental Solutions Inc. TOMZ's BIT solution by the Health and Safety Executive impact its market expansion strategy in Great Britain and Northern Ireland?
What competitive advantages does TOMI Environmental Solutions Inc. TOMZ anticipate gaining by having its SteraMist iHP brand authorized as a biocidal product in the UK market?
Can TOMI Environmental Solutions Inc. TOMZ provide insights into the anticipated timeline for EU Biocidal Products Regulation approval and its expected impact on sales in other European countries?
Given the efficacy claims established for TOMI Environmental Solutions Inc. TOMZ's BIT solution, how does the company plan to navigate potential regulatory challenges in different international markets?
**MWN-AI FAQ is based on asking OpenAI questions about TOMI Environmental Solutions Inc. (NASDAQ: TOMZ).
NASDAQ: TOMZ
TOMZ Trading
0.63% G/L:
$0.6573 Last:
2,629 Volume:
$0.647301 Open:
